P14S03: Atrial fibrillation

 

Bottom line: Information on atrial fibrillation was used to modify the management plan of the patient (drug already stopped, and not re-started with higher dose), and to persuade another health professional to make changes (no increase of drug dose). It contributed to avoid inappropriate treatment.

 

Level 1 outcome (situational relevance): On August 5, 2008, P14 did a search at work, by themselves, and after an encounter with a patient. They retrieved two information hits about atrial fibrillation. The reported search objectives were: to address a clinical question, to look up something they had forgotten, and to exchange information with other health professional. “[…] The resident had seen this patient [a man in his forties] […] who was having […] atrial fibrillation […] symptoms. The resident had said: “he [the patient] failed Sotalol, is there anything else we can use in this case?" And then, he [the resident] had said: "really, he’s [the patient] that young, maybe he should have catheter ablation [ablation of the left atrium] ". […][I] had to build my own knowledge base, before I could [answer]. […]. I had said to the resident "I think Diltiazem is also an option [for] this patient, but I will go double-check, because I didn't know if Diltiazem was an option if [they] [the patient] were symptomatic.” According to P14, the information from e-Therapeutics+ was relevant.

           

Level 2 outcome (cognitive impact): The first and the third hits were associated with a report of positive cognitive impact (see table). Regarding reminder, P14 stated: “I was reminded […] that Sotalol, which is another drug, has rhythm control as well as rate control [for atrial fibrillation].” The second hit was associated with a report of highly positive cognitive impact (learning). “I didn't know that atrial fibrillation [with symptoms] was treated differently than asymptomatic [atrial fibrillation].”

Retrieved information hit:

1) e-Therapeutics+ (CIRT): Therapeutics Tab – Keyword: Atrial fibrillation – Supraventricular tachycardia – Table 5: Drug therapy for control of heart rate (P14S03H01)

2) e-Therapeutics+ (CIRT): Therapeutics Tab – Keyword: Atrial fibrillation – Supraventricular tachycardia– Non-pharmacologic choices (P14S03H02)

3) e-Therapeutics+ (CIRT): Therapeutics Tab – Keyword: Atrial fibrillation – Supraventricular tachycardia– Non-pharmacologic choices– Catheter ablation– Pharmacologic choices – Printable version (P14S03H03)

 

Level 3 outcome (information use): Information on atrial fibrillation was retrieved, and used to better understand a specific issue with respect to the management of the patient, to modify the management plan of the patient (drug already stopped, and not re-started with higher dose), and to persuade other health professional to make change (information used as presented in e-Therapeutics+). “I actually printed the section (information) and gave it to the resident [...]. The patient actually wasn't responding to Sotalol, and the resident wanted to know if […] there was any use in putting the drug higher and I said "no" you’ve reached your target dose. […] I had to convince the resident that there was not really much use in going higher. I had to use this information to convince him. […] And so, what the resident decided was he wouldn't increase the dose of Sotalol, because the patient was going to see a cardiologist quite soon.”

 

Level 4 outcome (patient health): Regarding patient health, P14 reported that the information contributed to avoid inappropriate treatment. “[…] We avoided going to a higher dose that might have had adverse effects on the patient, but not any better outcomes in the treatment.”

 

 

Levels of outcome of information-seeking

 

Situational relevance

Positive cognitive impact

Information use

Patient health

Address a clinical question

Look up something forgotten

Exchange information

Learned something

Reminded something

Reassured

Persuade

Manage differently

Understand issue

Avoid

 

Home